Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
10/2008
10/16/2008US20080255146 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008CA2683682A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/15/2008EP1980560A2 C-glycoside derivatives for the treatment of diabetes
10/15/2008EP1979325A1 Morpholino pyrimidine derivatives and their use in therapy
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1603901B1 Tetrahydropyran compounds as tachykinin antagonists
10/15/2008EP1587585B1 Acylsulfonamide compounds as inhibitors of rna-dependent rna (viral) polymerases
10/15/2008CN101287728A Novel high affinity thiophene-based and furan-based kinase ligands
10/15/2008CN101287725A DNA-PK inhibitors
10/15/2008CN101287707A 激酶抑制剂 Kinase inhibitors
10/14/2008US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/14/2008CA2387727C Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008119716A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008101682A3 Iminipyridine derivatives and their uses as microbiocides
10/09/2008WO2008098978A3 Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
10/09/2008WO2008016811A3 Aminopiperidines and realted compounds
10/09/2008US20080249322 Processes for preparing crystalline and amorphous mupirocin calcium
10/09/2008US20080249252 New permanent surface modifiers
10/09/2008US20080249165 Glycosides and Salts Thereof
10/09/2008US20080249110 Novel Substituted 3-Sulfur Indoles
10/08/2008EP1976851A2 Phenoxy-substituted pyrimidines as adenosine receptor antagonists
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1295881B1 Compositions for treating or preventing malaria and method of treating malaria
10/08/2008CN101282967A Total synthesis of pladienolide b and pladienolide D
10/08/2008CN101282948A Phosphatidylinositol 3-kinase inhibitors and methods of their use
10/08/2008CN101282933A Novel NK1 and NK2 antagonists
10/07/2008US7432383 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
10/07/2008US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
10/02/2008US20080242721 Glycerol Levulinate Ketals and Their Use
10/02/2008US20080241742 Photoresists; using compound containing an orgaooxygen or organosulfur compound
10/01/2008EP1973892A1 Novel compounds and methods for forming taxanes and using the same
10/01/2008EP1973884A2 Novel heterocycles
10/01/2008EP1420780B1 Cyclopropyl and cyclobutyl epothilone analogs
09/2008
09/25/2008WO2008115381A1 Pyridazinone derivatives useful as glucan synthase inhibitors
09/25/2008US20080234503 Precipitation from aqueous solution; recovering precipitate; dissolving precipitate in solvent
09/25/2008US20080234258 Dihydroxyanthraquinones and Their Use
09/25/2008CA2680583A1 Pyridazinone derivatives useful as glucan synthase inhibitors
09/24/2008EP1723116B1 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/24/2008CN101270102A Process for synthesizing parthenolide derivative and uses thereof
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/18/2008WO2008112022A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/18/2008WO2008111300A1 Novel diamide derivative
09/18/2008WO2008110813A2 Controlled release system
09/18/2008WO2008110793A1 Piperidinones useful in the treatment of inflammation
09/18/2008WO2008110355A1 Quinoline derivatives as fungicides
09/18/2008CA2680412A1 Piperidinones useful in the treatment of inflammation
09/18/2008CA2680360A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/18/2008CA2679714A1 Quinoline derivatives as fungicides
09/17/2008EP1409477B1 Piperidine derivatives as nmda receptor antagonists
09/17/2008CN101268072A DNA-PK inhibitors
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/16/2008US7425631 Compounds and methods of use
09/12/2008WO2008109591A1 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
09/12/2008WO2008070016A3 Inhibitors of akt activity
09/11/2008US20080221204 Materials and Methods for Treating Coagulation Disorders
09/11/2008US20080221191 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens
09/11/2008US20080221163 behave as estrogen antagonists in the uterus that do not stimulate the ovaries; for treating endometriosis and uterine leiomyoma; 8-Methylsulfanyl-5-[4-(2-piperidin-1-yl-ethoxy)-phenyl-5H-6-oxa-chrysen-2-ol hydrochloride
09/11/2008US20080221125 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
09/11/2008US20080217585 Lactone stabilizing compositions
09/10/2008EP1966187A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases
09/10/2008EP1966139A1 Aspartic protease inhibitors
09/10/2008EP1966134A1 Novel fused pyrrole derivatives
09/10/2008CN101260105A Method for extracting silibinin
09/09/2008US7423058 Inhibitors of hepatitis C virus NS3 protease
09/04/2008US20080214661 Process To Obtain Dibenzylbutyrolactonic, Tetrahydrofuranic Lignans And Their Synthetic And Semi-Synthetic Derivatives, Their Analgesic And Anti-Inflammatory Activities, Topical And/Or Systemic Formulations Containing Said Lignans And Their Respective Therapeutic Method
09/04/2008US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic
09/04/2008US20080214589 Thrombin Inhibiting 2,4-Dioxo-3,4-Dihydropyrimidine Derivatives
09/03/2008EP1626720B1 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
09/03/2008CN101258147A Derivatives of 4-piperazin-1-yl-4-benz0[B]thiophene suitable for the treatment of CNS disorders
09/03/2008CN101258135A New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-HT6 mediated disorders such as alzheimer desease, cognitive disorders, cogn
09/03/2008CN100415730C Benzofuran derivative and its preparation and use
09/03/2008CN100415723C Benzimidazole derivative
09/02/2008US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
09/02/2008US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections
08/2008
08/28/2008WO2008101979A1 Quinoxaline compounds and use thereof
08/28/2008WO2008101682A2 Iminipyridine derivatives and their uses as microbiocides
08/28/2008WO2008081399A3 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
08/28/2008WO2008070041A3 Inhibitors of akt activity
08/28/2008US20080207927 Process for the production of glycerol acetals
08/28/2008US20080207926 Process for preparation of 13,14-dihydro-pgf2 alpha derivatives
08/28/2008US20080207616 Anticancer agents; for humans, animals
08/28/2008US20080207613 Selective Kinase Inhibitors
08/28/2008CA2677949A1 Iminipyridine derivatives and their uses as microbiocides
08/28/2008CA2675884A1 Quinoxaline compounds and use thereof
08/27/2008EP1960390A1 Biaryl compounds useful as agonists of the gpr38 receptor
08/27/2008EP1960368A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
08/27/2008EP1406895B1 Lactone formulations and method of use
08/27/2008CN101253167A Substituted imidazole compounds as KSP inhibitors
08/27/2008CN101253152A Amide derivatives as ROCK inhibitors
08/27/2008CN101252929A G-protein coupled receptor agonists
08/27/2008CN101250169A Method for synthesizing aliphatic diepoxides
08/27/2008CN100413860C Piperidine derivative as NMDA receptor antagonist
08/26/2008US7417156 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma
08/26/2008US7417069 Halogenated triptolide derivatives as immunomodulators and anticancer agents
08/26/2008US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole
08/26/2008CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols
08/26/2008CA2432129C Pyrazole compounds useful as protein kinase inhibitors
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 120